{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:18:24Z","timestamp":1792880304203,"version":"4.5.0"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.diabres.2021.108924","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T10:45:50Z","timestamp":1624013150000},"page":"108924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Hundred-year experience with insulin and lipohypertrophy: An unresolved issue"],"prefix":"10.1016","volume":"178","author":[{"given":"Paolo","family":"Di Bartolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Eckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice","family":"Strollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2021.108924_b0005","doi-asserted-by":"crossref","unstructured":"Di Bartolo P, Eckel RH. Living with Insulin: The story of insulin from people with diabetes. Diabetes Res Clin Pract. 2021 May 7;176:108857. doi: 10.1016\/j.diabres.2021.108857. Epub ahead of print. PMID: 33965450.","DOI":"10.1016\/j.diabres.2021.108857"},{"key":"10.1016\/j.diabres.2021.108924_b0010","doi-asserted-by":"crossref","unstructured":"Mohan V, Khunti K, Chan SP, et al. Management of Type 2 Diabetes in Developing Countries: Balancing Optimal Glycaemic Control and Outcomes with Affordability and Accessibility to Treatment. Diabetes Ther. 2020 Jan;11(1):15-35. doi: 10.1007\/s13300-019-00733-9. Epub 2019 Nov 26. PMID: 31773420; PMCID: PMC6965543.","DOI":"10.1007\/s13300-019-00733-9"},{"key":"10.1016\/j.diabres.2021.108924_b0015","doi-asserted-by":"crossref","unstructured":"Beran D, Mirza Z, Dong J. Access to insulin: applying the concept of security of supply to medicines. Bull World Health Organ. 2019 May 1;97(5):358-364. doi: 10.2471\/BLT.18.217612. Epub 2019 Mar 26. PMID: 31551632; PMCID: PMC6747032.","DOI":"10.2471\/BLT.18.217612"},{"issue":"9","key":"10.1016\/j.diabres.2021.108924_b0020","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s13300-020-00876-0","article-title":"Insulin-induced skin lipohypertrophy in type 2 diabetes: a multicenter regional survey in Southern Italy","volume":"11","author":"Gentile","year":"2020","journal-title":"Diabetes Ther"},{"issue":"3","key":"10.1016\/j.diabres.2021.108924_b0025","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/jdi.12742","article-title":"Prevalence of lipohypertrophy in insulin-treated diabetes patients: a systematic review and meta-analysis","volume":"9","author":"Deng","year":"2017","journal-title":"J Diabetes Investig"},{"issue":"1","key":"10.1016\/j.diabres.2021.108924_b0030","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.dsx.2018.11.042","article-title":"Why are so huge differences reported in the occurrence rate of skin lipohypertrophy? Does it depend on method defects or on lack of interest?","volume":"13","author":"Gentile","year":"2019","journal-title":"Diabetes Metab Syndr"},{"issue":"1","key":"10.1016\/j.diabres.2021.108924_b0035","first-page":"1","article-title":"A cry of pain for painless insulin lipohypertrophy","volume":"2","author":"Gentile","year":"2020","journal-title":"J Diab Res Rev & Rep"},{"issue":"2","key":"10.1016\/j.diabres.2021.108924_b0040","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s13300-019-0574-x","article-title":"EADSG guidelines: insulin storage and optimisation of injection technique in diabetes management","volume":"10","author":"Bahendeka","year":"2019","journal-title":"Diabetes Ther"},{"issue":"9","key":"10.1016\/j.diabres.2021.108924_b0045","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.mayocp.2016.06.010","article-title":"New insulin delivery recommendations","volume":"91","author":"Frid","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.diabres.2021.108924_b0050","first-page":"3","article-title":"AMD-OSDI consensus on injection techniques for people with diabetes mellitus","volume":"2","author":"Gentile","year":"2016","journal-title":"Med Clin Rev"},{"issue":"5","key":"10.1016\/j.diabres.2021.108924_b0055","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1186\/s40064-016-1978-y","article-title":"A suitable palpation technique allows to identify skin lipohypertrophic lesions in insulin-treated people with diabetes","volume":"5","author":"Gentile","year":"2016","journal-title":"Springerplus"},{"key":"10.1016\/j.diabres.2021.108924_b0060","doi-asserted-by":"crossref","unstructured":"Gentile S, Strollo F, Guarino G. Factors hindering correct identification of unapparent lipohypertrophy. J Diabetes Metab Disord Control. 2016; 3(2): 42\u20137. 10.15406\/jdmdc.2016.03.00065.","DOI":"10.15406\/jdmdc.2016.03.00065"},{"issue":"5","key":"10.1016\/j.diabres.2021.108924_b0065","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s13300-021-01006-0","article-title":"Role of structured education in reducing lypodystrophy and its metabolic complications in insulin-treated people with type 2 diabetes: a randomized multicenter case-control study","volume":"12","author":"Gentile","year":"2021","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.diabres.2021.108924_b0070","first-page":"729","article-title":"Lipoatrophy following the injection of insulin","volume":"2","author":"Williams","year":"1922","journal-title":"J Metab Res"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822721002849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822721002849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:18:08Z","timestamp":1759173488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822721002849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":14,"alternative-id":["S0168822721002849"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2021.108924","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hundred-year experience with insulin and lipohypertrophy: An unresolved issue","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2021.108924","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108924"}}